glp-1/gip agonists GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications The dual glucose-dependent insulinotropic polypeptide
Description
Front Oncol
The epidemiology of obesity: a big picture
Hashimoto Takigami N, Kuniyoshi S, Miki Y, Tamaki K, Kamada Y, Uehara K, et al
Cancel at least 72 hours before your next billing date
Prescription Medications to Treat Overweight and Obesity
It was not clear how a drug that primarily affects glucose metabolism might directly impact the occurrence of cardiovascular events
